Immune modulation in humans: implications for type 1 diabetes mellitus.
about
Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic PathologiesCurrent stem cell based therapies in diabetesHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairImmunogenetics of type 1 diabetes mellitusImmune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD MiceSpatiotemporal Dynamics of Insulitis in Human Type 1 DiabetesCombination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial.Understanding the role of gut microbiome in metabolic disease risk.Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic miceSET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β CellThe Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 DiabetesIRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation.Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort studyInterleukin 2 Topical Cream for Treatment of Diabetic Foot Ulcer: Experiment ProtocolThioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model.Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccinationTargeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies.The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.Islet inflammation in human type 1 diabetes mellitus.Understanding the complexity and malleability of T-cell recognition.How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.Galectin-3 in autoimmunity and autoimmune diseases.Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial.Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection.Enteroviruses and Type 1 Diabetes: Candidate Genes Linked With Innate Immune ResponseImmunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials.FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.Hospital time prior to death and pancreas histopathology: implications for future studies.Type 1 diabetes induction in humanized mice.Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.The subcellular distribution of cyclin-D1 and cyclin-D3 within human islet cells varies according to the status of the pancreas donor.Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes.Changing perspectives on the progression of type 1 diabetes
P2860
Q26740176-7DF9D821-A3B9-46A2-9C48-C662E23427E5Q26782979-280BC871-BDA5-491D-98BD-97D2958C4002Q28074914-AAA95D73-912D-4708-8DED-6E3CE34ECD8AQ28078211-E963E1C8-8A9B-4600-BA41-FEB63BE3B71EQ28087365-22D5348D-D91C-4E75-B4F6-8CA9485BBAA9Q28551036-4A91DA4E-1E47-4BC5-B85C-5A3C463DDC57Q30833054-E7891F31-FC8C-47F0-BD3F-D1A23B02D907Q34813843-8C8895CB-0A2D-42E9-973D-1B0C1AB39ED5Q35331225-ED197B92-2318-4B6C-8C93-34D51464A1B2Q35741902-042EE60F-8574-4367-8FB6-6D7391F4A208Q35860498-10152D65-BD67-449C-8177-55357F4A237BQ35903101-D61CEE79-E7FD-4BD4-AB1A-6C965A16DB25Q36059366-051FF3F0-1500-4BA1-B8C6-DC4E9BB50E2BQ36181583-0AC257B3-2DA0-4CA2-97CA-7089129393E8Q36441368-37DB5E9A-DBEA-4F0E-A2A1-90A713512823Q36637650-FFDE00C3-4530-436F-9C43-9FC77F5061DAQ37089336-74EF3362-AB05-4F48-9BDE-47426AA13F75Q37342952-8EF6B354-998D-4BA6-8C71-3FFA27B8199CQ37652799-D10FCB26-2F12-4224-A7E9-D6364EAE01C6Q38287783-2C4B974F-3989-44DD-BD17-0F36554BED06Q38315875-EE61DDB4-013E-415A-8F0A-7C395AE33CF3Q38325456-F8321E1F-6D63-4311-BA74-923D8D32C9ACQ38365047-37A6FFD5-0919-4527-9688-2DB647AE974EQ38542678-559E3B0C-7298-4411-B8FE-7DACC446DD10Q40080595-67F7EFEE-356E-4F2C-88D4-F9C4CE2C99E8Q41135035-A6E2A176-7F7B-402B-9B21-556F57752692Q41470100-34ABCDD7-3547-4443-B3BF-2A669C7A3BCDQ42320502-EA889DFE-E146-41CD-8275-9587F26D270AQ47101639-1B286551-60B3-4B64-A07B-FCD47669C7D9Q47128789-BD6EFB99-1FAF-4183-84F3-ACDB32E6DE5BQ47132703-768A0FE7-8874-428E-A156-FEF3E26419A7Q47565392-A8F6C00E-7131-4E46-A88B-8DCD3A2AD619Q47569628-1A30348B-1234-4A18-95BB-EA63657574BCQ48175684-AF8C3A2C-5648-4DF7-B71A-3CFA14832C29Q52725158-A30F8E46-E003-4584-BD72-48AC3491D90CQ52937948-920841C2-394D-4CE4-BFA8-14CB1CC03EE9Q55408800-22EB3CC1-C865-4BAF-B00C-EDE9912EACECQ57917243-C2182D3E-FABC-475C-908D-D39873C48C7E
P2860
Immune modulation in humans: implications for type 1 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune modulation in humans: implications for type 1 diabetes mellitus.
@en
type
label
Immune modulation in humans: implications for type 1 diabetes mellitus.
@en
prefLabel
Immune modulation in humans: implications for type 1 diabetes mellitus.
@en
P2860
P356
P1476
Immune modulation in humans: implications for type 1 diabetes mellitus
@en
P2093
Bart O Roep
P2860
P2888
P304
P356
10.1038/NRENDO.2014.2
P50
P577
2014-01-28T00:00:00Z